Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Outokumpu – Manager transaction: Roeland Baan

Outokumpu OyjStock exchange releaseManager transactionDecember 30, 2019 at 3.00 pm EETOutokumpu – Manager transaction: Roeland Baan Outokumpu has received a notification from Roeland Baan, CEO, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name of the manager Roeland BaanPosition in the issuer CEOIssuer Outokumpu OyjIssuer’s LEI reference 5493009YRUJJDCFF0R80Notification type Initial notificationDate of the

#19-1180  Trade halt in certain instruments due to early closing in Germany

The German markets close today at 14:00 and certain instruments will for that reason be trade halted at the above-mentioned time.Trading and market making in the affected instruments will be resumed on the 2[nd] of January 2020. For more information concerning the affected instruments, please check our website www.ngm.se or contact the issuers of the instruments in question. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB

Vestas secures 37 MW order in Italy for 2 MW and 4 MW platform turbines

News release from Vestas MediterraneanMadrid, 30 December 2019 PLT Engineering has placed a 37 MW order for two projects in Italy that showcase the versatility of Vestas’ 2 MW and 4 MW platforms. Both projects, located in Calabria and Basilicata, will feature a mixed site configuration of both V110–2.0 MW and V136–4.2 MW wind turbines to optimise energy production. The order includes supply and installation of the turbines as well as an Active Output Management 5000 (AOM 5000) service agreement for the next 15 years.  The energy produced by both wind parks will be commercialised

Enfo Oyj’s rights issue

The Board of Directors of Enfo Oyj (Enfo) has on December 30, 2019 resolved on a rights issue of approximately EUR 4.2 million with pre-emptive subscription right for existing shareholders, based on the authorization granted by the Annual General Meeting held on March 27, 2019.The proceeds from the rights issue will be used to finance the acquisition of the SAP ERP business of Solteq Oyj.  The rights issue in short: · Enfo issues for subscription a maximum of 82,233 new shares to the existing shareholders in a rights issue (rights issue). · The existing shareholders of the

Revenio Group Corporation - Managers' Transactions

Stock Exchange Release, Managers' Transactions, December 30, 2019 at 14.15Revenio Group Corporation - Managers' Transactions____________________________________________ Person subject to the notification requirementName: Hildén TimoPosition: Chief Executive Officer(X) Legal personIssuer: Revenio Group CorporationLEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATIONReference number: 743700I27E0FWSXLKK04_20191230134617_2____________________________________________ Transaction date: 2019-12-30Venue: FIRST NORTH FINLAND (FNFI)Instrument type: FINANCIAL

New number of shares and votes in K-Fast Holding AB

The number of shares and votes in K-Fast Holding AB has increased with 8,625,000, following the new issues of shares in connection with the listing on Nasdaq Stockholm on 29 November 2019 and the exercise of the overallotment option on 5 December 2019.On 30 December 2019, the last trading day of the month, the total number of shares in the company amounts to 33,888,528, whereof 7,500,000 class A shares and 30,138,528 class B shares. Class A shares represents 18,750,000 votes and class B shares represents 30,138,528 votes, total number of votes in K-Fast Holding amounts to 48,888,528. The

New number of votes in AB Volvo

The number of votes in AB Volvo has changed due to the conversion of a total of 441 304 Series A shares to a total of 441 304 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting.Today, 30 December 2019, the last trading day of the month, there are a total of 2,128,420,220 registered shares in AB Volvo. Of these are 476,912,471 Series A shares and 1,651,507,749 Series B shares. The number of

The Board of Directors of NoHo Partners Plc resolved on a second earning period of the company’s share-based incentive plan for key employees

NoHo Partners PlcSTOCK EXCHANGE RELEASE 30 December 2019 at 14:00The Board of Directors of NoHo Partners Plc resolved on a second earning period of the company’s share-based incentive plan for key employeesThe Board of Directors of NoHo Partners Plc has resolved on a second earning period of the long-term share-based incentive plan targeted to key employees of the company. The second 24 moths earning period starts on 1 January 2020 and ends on 31 December 2021. The aim of the incentive plan is to combine the objectives of the shareholders and the key personnel in order to increase the

SSM secures long-term loan financing – signs 2-year agreement to refinance company’s real estate loans

Today, as a step in safeguarding the company’s long-term loan financing, SSM Holding AB (publ) signed a two-year 114 MSEK loan agreement to refinance all of the company’s real estate loans. SSM already has a conditional agreement in place with the majority of the company’s bondholders to extend the company’s bond, which matures in May 2020. Costs for work to refinance the company’s real estate loans and bond will be expensed in the fourth quarter 2019 as a non-recurring item of approximately 14 MSEK.During 2019, SSM has taken measures to secure the company’s long-term financing and

Nordea has completed sale of LR Realkredit

Nordea announced on 11 April 2019 that the bank had entered into an agreement to sell all its shares in the Danish mortgage institution LR Realkredit A/S (“LR Realkredit”) to Nykredit. As previously announced, the transaction was subject to customary regulatory approvals. Those approvals have now been received and the transaction was completed today. As stated in the press release dated 11 April 2019, Nordea is selling its shares in LR Realkredit to focus on its core business and to find a better long-term solution for LR Realkredit. The purchase price for Nordea’s 39 per cent of LR

Changed number of shares and votes in RNB

As a result of the rights issue completed by RNB RETAIL AND BRANDS AB (publ) ("RNB" or "the Company") during December, the number of shares and votes in the Company has changed.The shares subscribed with and without the support of subscription rights were registered with the Swedish Companies Registration Office in December. As a result, the total number of shares in RNB has increased by 67,824,352 shares, corresponding to the same number of votes. The rights issue is thus fully registered. As of December 30, 2019, the total number of shares and votes in RNB totaled 101,736,528 shares

Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)

Lund, Sweden, 12:00 pm CET, 30 December 2019 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes. During December, the number of shares and votes in BONESUPPORT HOLDING AB (publ) has increased with 60,000 due to the exercise of warrants. As of 31 December 2019, the number of shares in BONESUPPORT HOLDING AB (publ) amounts to 52,521,342 shares, of which 52,016,342 are ordinary shares with one vote per share and 505,000 are series C shares with one-tenth of a vote per share. The

Redsense offsets loan raised in connection with directed share issue

The Board of Directors of Redsense Medical AB (publ.) has resolved, in accordance with the authorization given by the Annual General Meeting on 6 May 2019, to increase the Company’s share capital with SEK 36,589.60 through a directed new share issue.The new share issue is directed to Gerhard Dal, Modelio Equity AB, and Pong AB. The share price is set to SEK 11.03 under the agreement, which corresponds to a 10 percent discount compared to the volume-weighted average price during the period between 2019-12-03 and 2019-10-23. The amount of the loan offset by the issue is MSEK 4 plus interest.

Change in number of shares and votes

The seventh opportunity to convert debentures into shares under the staff convertible debenture programme decided by the Annual General Meeting 2016 occurred in December 2019. Through the conversion, the numbers of B-shares and votes have increased by 5 980. Before the conversion:   After the conversion:A-shares: 4 290 336   A-shares: 4 290 336B-shares: 107 877 812   B-shares:   107 883 792   Total shares: 112 168 148   Total shares:   112 174 128   Total votes: 150 781 172   Total votes:     150 787 152      Corporate

Vestas secures 252 MW order for three wind energy projects in Russia

News release from Vestas Northern and Central EuropeHamburg, 30 December 2019 Vestas has been awarded an order for 252 MW for three wind energy projects in Russia from WEDF (Wind Energy Development Fund), a joint investment fund created on a parity basis by PJSC Fortum and JSC RUSNANO. Located in the Kalmykiya and the Rostov region, the projects will comprise 60 V126-4.2 MW wind turbines. With this fourth order from its framework agreement with RUSNANO and Fortum to supply wind energy solutions in Russia, Vestas marks another key milestone in further strengthening the country’s

Conversion of shares in NCC AB

According to NCC’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During August 2019, 42 290 Series A shares were converted to Series B shares at the request of shareholders, following which the total number of voting rights in the company amounts to 227 317 983. The total number of registered shares in the company amount to 108,435,822, of which 13 209 129 are Series A and 95 226 693 are Series B. NCC holds 530,267 Series B shares in treasury.

Read original

Update on Traumakine drug substance manufacturing

Faron Pharmaceuticals Oy   Update on Traumakine drug substance manufacturing              -     Faron contests termination of the agreement and files for arbitration   -     Proceedings funded by a third party on a non-recourse basis   Company announcement, 30 December 2019 at 11.30 am (EET)Inside information   TURKU - FINLAND - Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON) ("Faron" or the "Company"), the clinical stage biopharmaceutical company, announces that, further to the update on Traumakine® drug substance ("API") manufacturing announced on

New number of shares and votes in Nolato AB (publ)

The incentive programme for senior executives that was introduced at the extraordinary general meeting of 5 December 2016 entitles holders of Series 1 share warrants to subscribe for new shares in the company between 1 May and 15 December 2019. In December a total of 3,540 Class B shares were subscribed for through the exercise of share warrants received from the incentive programme. Prior to the issue of the new shares there were 26,544,468 shares and 51,379,068 votes in the company. At 30 December 2019 there are a total of 26,548,008 shares and 51,382,608 votes in the company. These

Herantis Pharma Plc provides update on non-invasive next generation CDNF (xCDNF) development

Herantis Pharma PlcCompany release, insider information 30 December 2019 at 11:00 AM Eastern European TimeHerantis Pharma Plc (“Herantis” or “Company”) announced today an update on the development of its non-invasive next generation CDNF, or xCDNF. The xCDNF development program was initiated in July 2018 to develop cell-protecting molecules that penetrate the blood-brain barrier, building on the Company’s cumulated expertise on CDNF, Herantis’ lead compound in Parkinson disease. The xCDNF program is based on the discovery of certain CDNF-derived peptides penetrating the blood-brain

Number of shares and votes in Medicover

The number of votes in Medicover  AB (publ) (“Medicover”) has changed as a result of conversions of in total 25,000 class A shares into class B shares carried out in December following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 135,735,195 shares in Medicover, of which 78,771,431 are class A shares, together carrying 78,771,431 votes, 54,563,764 are class B shares, together carrying 5,456,376.4 votes and 2,400,000 are class C shares,

Enfo acquires SAP ERP expertise from Solteq

Enfo has agreed to acquire Solteq’s SAP ERP business, with some 20 SAP experts.“Enfo’s strategy is to support its customers in moving business-critical applications and data to a cross-platform environment. This requires strong software engineering competence, solid data management expertise and seamless 24/7 support. SAP is a market leader in enterprise resource planning and management systems. With this deal we build a foundation to become a Nordic leader in SAP on cloud migration and maintenance services,” says Enfo’s CEO Seppo Kuula.  “What we see now in the market is that not only

Change in number of shares outstanding in Sectra during December

Press release – Linköping, Sweden, December 30, 2019 – During December, the number of shares outstanding in the medical imaging IT and cybersecurity company Sectra  AB (STO: SECT B) increased by 153,149 ordinary Class B shares. As of December 30, 2019, the number of shares totals 38,506,020.The change was attributable to a new share issue in connection with the conversion of Sectra’s convertible debenture programs  2015/2019 and 2016/2019.  The number of shares after the change

Elkem acquires Polysil, a leading Chinese silicone elastomer & resins company

Elkem ASA has entered into an agreement to acquire all of the shares in Polysil, a leading Chinese silicone elastomer & resins material manufacturer with strong positions in baby care and food grade silicones, as well as silicone products for the electronics and medical markets. Polysil and Elkem’s complementary product and market positions provide a solid platform for further specialisation and growth in China and globally.Polysil is a privately owned company with more than 400 employees located in Zhongshan in Guangdong, China. The company has leading technology positions in production

Solteq Plc selling its SAP ERP business to Enfo Oyj

Stock Exchange Bulletin 30.12.2019 On December 30, 2019, Solteq Plc signed a business transfer agreement, whereby the company's SAP ERP business, including its current employees and customers, will be transferred to Enfo Oyj, effective on January 1, 2020.The debt-free purchase price of Solteq's SAP ERP business is EUR 4.275 million, which will be paid in cash by March 15, 2020. The company will recognize the estimated, additional one-time profit of EUR 2.3 million for the fiscal year 2019.  Following the SAP ERP asset deal, Solteq will focus even more on the development of its own

There are no items matching the current filter
There are no more items matching the current filter
Back to top